CD200Fc attenuates LPS-induced neuroinflammation and motor deficits via modulation of microglial activation and autophagy
This study investigated the therapeutic potential of CD200Fc in a mouse model of chronic neuroinflammation induced by intraperitoneal lipopolysaccharide (LPS) injections administered every other day for four weeks. Wild-type mice (Male mice aged 8 weeks) were divided into four groups: WT + PBS, WT + LPS, LPS + PBS,...